J.D. Vance's investment in a biotech firm that does testing on live animals is raising questions about the Ohio Senate candidate's true values.

cross-posted from: https://slrpnk.net/post/11812644

AmplifyBio does not ask whether the drugs it tests are developed with fetal or embryonic cells, nor, it insists, would it turn away such business. “We do not have any policy that would require our clients to disclose those types of development details,” it says. “To have that policy could limit the clients we work with.”

Far from the shiny face of biotech, AmplifyBio represents a little-scrutinized dark side of the industry, in which advances in human health require the deaths of primates, dogs, and other animals.